Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets, net (Details Narrative)

v3.23.1
Intangible Assets, net (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended
Oct. 05, 2021
Mar. 31, 2023
Mar. 31, 2022
Dec. 31, 2022
Apr. 02, 2022
Impairment Effects on Earnings Per Share [Line Items]          
Intangible assets   $ 5,305   $ 5,305  
Accumulated amortization   (2,365)   $ (1,860)  
Amortization expense of intangible assets   $ 505    
Defensive Technology [Member] | Pavmed Inc [Member]          
Impairment Effects on Earnings Per Share [Line Items]          
Intangible assets         $ 2,100
Accumulated amortization         $ 200
Purchase consideration paid $ 2,100        
Finite lived intangible asset useful life   60 months